A new study is out that compares the effectiveness of two popular weight loss drugs, Wegovy and Zepbound. The study, which ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical ...
With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more ...
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Doctors say early obesity intervention can help prevent later health problems. But prescribing GLP-1s, such as Ozempic and ...
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a ...
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.
Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...
(AP Photo/David J. Phillip, File)(David J. Phillip / ASSOCIATED PRESS) WASHINGTON — Millions of Americans with obesity would ...
such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight loss, researchers and medical professionals have raised concerns about ...